| Model Number |
N/A |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/30/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The customer contacted the siemens customer care center (ccc) to report a discordant, falsely elevated atellica im troponin i ultra (tni-ultra) result on a patient sample.Quality control (qc) results were within acceptable ranges.Siemens is investigating.The instruction for use (ifu) states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".
|
| |
|
Event or Problem Description
|
|
A discordant, falsely elevated atellica im troponin i ultra (tni-ultra) result was obtained by the customer on a patient sample and questioned by the physician(s).The same sample was repeated twice, resulting lower.The lower tni-ultra result was reported to the physician(s) as the corrected result.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant, falsely elevated atellica im troponin i ultra (tni-ultra) result.
|
| |
|
Additional Manufacturer Narrative
|
|
Mdr 1219913-2020-00416 was filed on 28-oct-2020 for a discordant, falsely elevated atellica im troponin i ultra (tni-ultra) result on a patient sample.On 30-nov-2020 additional information: siemens has concluded the investigation.Quality control (qc) results were within range at the time of the incident.There were no other patient results affected which is indicative of a sample specific issue.The customer uses a stat spin protocol to process their samples for troponin i ultra (tni-ultra) testing.Sample collection tubes (7 ml) are spun by the customer for 5 minutes as 3400 rpm, however the sample collection tube manufacturer recommends spinning sample tubes for 10 minutes.Pre-analytic variables can affect the quality of the sample, and deviation from recommended best practices can lead to erroneous results.Based on the information provided, the cause for the discordant, falsely elevated atellica im troponin i ultra (tni-ultra) is unknown, however pre-analytical factors or a sample issue cannot be ruled out.A product performance issue was not confirmed.The customer is operational.The assay is performing within specifications.No further evaluation of the device is required.In section h6, the investigation findings code and the investigation conclusions codes were revised.
|
| |
|
Search Alerts/Recalls
|